UDP-galactose: β-D-galactose-R 4-α-D-galactosyltransferase, α4Gal-T1
A novel gene defining a novel enzyme UDP-galactose: β-D-galactose-R 4-α-D-galactosyltransferase, termed α4Gal-T1, with unique enzymatic properties is disclosed. The invention provides isolated DNA molecules and DNA constructs encoding α4Gal-T1 and derivatives thereof by way of amino acid deletion, substitution or insertion exhibiting α4Gal-T1 activity, as well as cloning and expression vectors including such DNA, host cells comprising DNA encoding α4Gal-T1, and recombinant methods for providing α4Gal-T1. The enzyme α4Gal-T1 and α4Gal-active derivatives thereof are disclosed. Further, the invention discloses methods of obtaining α1, 4galactosyl glycosylated glycosphingolipids by use of an enzymatically active α4Gal-T1 protein thereof or by using cells stably transfected with a vector including DNA encoding an enzymatically active α4Gal-T1 protein as an expression system for recombinant production of such glycosphingolipids. Also a method for the identification of DNA sequence variations in the α4Gal-T1-coding exon by PCR, and detecting the presence of DNA sequence variation, are disclosed.
1. An isolated polypeptide comprising amino acids 46-353 of SEQ ID NO: 11, said polypeptide having UDP-galactose: β-D-galactose-R4-α-D-galactosyltransferase (α4Gal-T1) enzyme activity.
2. An isolated polypeptide comprising an amino acid sequence at least 95% identical to amino acids 46-353 of SEQ ID NO: 11, said polypeptide having UDP-galactose: β-D-galactose-R4-α-D-galactosyltransferase (α4Gal-T1) enzyme activity.
3. A polypeptide prepared in accordance with a method comprising:
(a) introducing into a host cell a nucleic acid encoding a polypeptide with UDP-galactose: βD-galactose-R4-α-D-galactosyltransferase (α4Gal-T1) enzyme activity;
(b) growing the host cell under conditions suitable for expression of the polypeptide; and
(c) isolating the polypeptide produced by the host cell, wherein the polypeptide with α4Gal-T1 enzyme activity is selected from the group consisting of:
(i) a polypeptide comprising amino acids 46-353 of SEQ ID NO: 11; and
(ii) a polypeptide comprising an amino acid sequence at least 95% identical to amino acids 46-353 of SEQ ID NO: 11.
4. A method for preparing an oligosaccharide comprising contacting a reaction mixture comprising a donor substrate and an acceptor substrate in the presence of the polypeptide of claim 1 .
5. A method for preparing an oligosaccharide comprising contacting a reaction mixture comprising a donor substrate and an acceptor substrate in the presence of the polypeptide of claim 2 .
6. A method for preparing an oligosaccharide comprising contacting a reaction mixture comprising a donor substrate and an acceptor substrate in the presence of the polypeptide of claim 3 .
7. A composition comprising the polypeptide of claim 1 and a pharmaceutically acceptable carrier, excipient or diluent.
8. A composition comprising the polypeptide of claim 2 and a pharmaceutically acceptable carrier, excipient or diluent.
9. A composition comprising the polypeptide of claim 3 and a pharmaceutically acceptable carrier, excipient or diluent.
10. An isolated polypeptide consisting of amino acids 46-353 of SEQ ID NO: 11.
11. An isolated polypeptide consisting of an amino acid sequence at least 95% identical to amino acids 46-353 of SEQ ID NO: 11, said polypeptide having with UDP-galactose: β-D-galactose-R4-β-D-galactosyltransferase (β4Gal-T1) enzyme activity.